Show simple item record

dc.contributorUniversitat Ramon Llull. Facultat de Ciències de la Salut Blanquerna
dc.contributor.authorGarin, Noe
dc.contributor.authorSole, Nuria
dc.contributor.authorLucas, Beatriz
dc.contributor.authorMatas, Laia
dc.contributor.authorMoras, Desiree
dc.contributor.authorRodrigo-Troyano, Ana
dc.contributor.authorGras-Martin, Laura
dc.contributor.authorFonts, Nuria
dc.date.accessioned2025-02-28T18:51:04Z
dc.date.available2025-02-28T18:51:04Z
dc.date.created2020-05
dc.date.issued2021-01
dc.identifier.urihttp://hdl.handle.net/20.500.14342/5070
dc.description.abstractDrug-related problems (DRP) cause preventable negative health outcomes, especially during hospital admissions. The aim of our study was to examine the prevalence and characteristics of DRP in regular clinical pharmacy, as well as to determine those factors associated with a higher risk of DRP in the hospital setting. We analyzed data from a standardized registry database of regular pharmacy practice (2015- 2016). DRP were classified according to the Pharmaceutical Care Network Europe v6.2 classification. Cross-sectional data were obtained from 1602 adults admitted to medical wards. Crude and adjusted binary logistic regressions were performed to identify associations between potential risk factors and DRP. Overall DRP prevalence was high across medical specialties (45,1%), in a population characterized by advanced age, polypharmacy and multimorbidity. Problems leading to DRP were mainly classified into two domains (effectiveness and adverse reactions), being drug and dose selection the most frequent causes. Interventions were accepted and DRP were totally or partially solved in 74.1% and 4.81% of cases, respectively. In the adjusted model polypharmacy, allergies, BMI > 25 kg/m2 and clearance < 30 mL/min were associated with a higher risk of DRP. The participation of clinical pharmacists into multidisciplinary teams promotes the detection and solution of DRP. Polypharmacy, obesity, renal impairment and allergy are associated with a higher risk of DRP during admission.ca
dc.format.extent11 p.ca
dc.language.isoengca
dc.publisherSpringer Natureca
dc.relation.ispartofScientific reports, 2021, 11, 883ca
dc.rights© L'autor/aca
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.otherMedicaments -- Administracióca
dc.subject.otherMedicaments -- Efectes secundarisca
dc.subject.otherFarmàcies d'hospitalca
dc.subject.otherFarmàcia clínicaca
dc.titleDrug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventionsca
dc.typeinfo:eu-repo/semantics/articleca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.identifier.doihttps://doi.org/10.1038/s41598-020-80560-2ca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

© L'autor/a
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint